Share Price and Basic Stock Data
Last Updated: January 29, 2026, 10:18 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Cambridge Technology Enterprises Ltd operates in the IT consulting and software sector, with its current stock price standing at ₹33.0 and a market capitalization of ₹64.7 Cr. The company has shown a fluctuating revenue trend, with reported sales of ₹182 Cr for FY 2023, a rise from ₹112 Cr in FY 2022. However, FY 2025 recorded a slight decline in sales to ₹199 Cr. Quarterly sales for the period ending March 2024 peaked at ₹57.07 Cr but saw a dip to ₹43.52 Cr by September 2023. This inconsistency signals potential volatility in demand or operational challenges. The company reported an average quarterly revenue of ₹52.89 Cr in the December 2023 quarter, indicating a possible stabilization phase. Over the years, Cambridge Technology has faced challenges in maintaining sales growth, particularly when compared to the sector’s typical growth rates, which often exceed 15% annually. The company’s ability to adapt its business model in response to market demands will be crucial for future revenue generation.
Profitability and Efficiency Metrics
Cambridge Technology’s profitability metrics indicate significant challenges, with a net profit of -₹15 Cr reported for FY 2025, a stark contrast to the ₹8 Cr recorded in FY 2023. The operating profit margin (OPM) stood at -0.09%, reflecting ongoing inefficiencies in managing operational costs. The company experienced a sharp decline in quarterly operating profit, which fell to -₹23.51 Cr in September 2024. Despite these hurdles, the return on equity (ROE) was reported at an impressive 53.0%, indicating that the company is generating strong returns on shareholder investments, albeit from a lower base. The interest coverage ratio (ICR) of -2.30x further complicates the financial landscape, suggesting that the company is struggling to meet its interest obligations. This duality of high ROE alongside negative profitability metrics paints a complex picture of operational efficiency, highlighting the need for strategic improvements in cost management and revenue generation.
Balance Sheet Strength and Financial Ratios
Cambridge Technology’s balance sheet reveals a mix of strengths and weaknesses. Reserves stood at ₹48 Cr, while borrowings were recorded at ₹80 Cr, leading to a total debt-to-equity ratio of 1.27x, which is relatively high compared to industry standards. The current ratio of 1.63x indicates adequate liquidity to cover short-term liabilities, yet the interest coverage ratio’s negative value raises concerns about financial sustainability. The book value per share decreased to ₹34.61 in FY 2025 from ₹57.29 in FY 2024, reflecting a decline in net asset values. Additionally, the company reported a cash conversion cycle (CCC) of 91 days, a figure that suggests some inefficiencies in working capital management. The enterprise value (EV) of ₹132.94 Cr versus the net operating revenue of ₹196 Cr highlights a valuation that may be under pressure, given the operational losses. These financial ratios indicate a pressing need for the company to improve its operational efficiency and financial stability to attract investor confidence.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Cambridge Technology Enterprises Ltd reveals a significant promoter holding of 50.91%, which can provide stability in governance and strategic direction. However, the absence of foreign institutional investment (FIIs) and the public holding of 47.15% suggest a cautious sentiment among broader investors. Over the recent quarters, the number of shareholders has seen fluctuations, with a rise to 12,160 in September 2025 from 11,240 in September 2023, indicating growing interest or retention among retail investors. The consistent promoter stake, alongside minimal fluctuations in FIIs, indicates a potential lack of confidence from institutional investors, which may be attributed to the company’s recent financial performance. The presence of domestic institutional investors (DIIs) remains unreported, potentially limiting larger capital inflows. This investor landscape emphasizes the importance of improving operational performance to enhance shareholder value and attract diverse investments.
Outlook, Risks, and Final Insight
Cambridge Technology Enterprises Ltd faces a challenging outlook, primarily driven by its recent financial performance. The risks include persistent operational inefficiencies reflected in declining profit margins and a high debt-to-equity ratio, which may strain future growth. Additionally, the negative interest coverage ratio raises concerns regarding the company’s ability to service its debt. On the other hand, strengths such as a high ROE and promoter confidence may provide a foundation for potential recovery. The company must prioritize operational improvements and strategic cost management to regain profitability and investor trust. Future scenarios could involve either a turnaround through enhanced operational efficiency, leading to improved financial health, or continued struggles that could prompt deeper restructuring. The path ahead necessitates focused management action to navigate these complexities and capitalize on any market opportunities.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| IDream Film Infrastructure Company Ltd | 4.99 Cr. | 332 | 332/108 | 302 | 0.00 % | % | % | 10.0 | |
| I Power Solutions India Ltd | 13.2 Cr. | 22.3 | 22.3/15.1 | 11.0 | 0.00 % | 11.6 % | 16.9 % | 10.0 | |
| Hypersoft Technologies Ltd | 92.2 Cr. | 56.8 | 101/19.4 | 45.2 | 9.97 | 0.00 % | 20.6 % | 9.07 % | 10.0 |
| Euphoria Infotech (India) Ltd | 11.6 Cr. | 40.0 | 64.9/33.1 | 7.84 | 58.7 | 0.00 % | 16.2 % | 11.5 % | 10.0 |
| AccelerateBS India Ltd | 42.2 Cr. | 123 | 145/67.0 | 28.7 | 15.0 | 0.82 % | 22.2 % | 17.6 % | 10.0 |
| Industry Average | 128,865.60 Cr | 800.49 | 43.58 | 156.22 | 0.78% | 20.61% | 18.63% | 7.00 |
All Competitor Stocks of Cambridge Technology Enterprises Ltd
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 41.49 | 42.48 | 61.63 | 52.75 | 43.52 | 52.89 | 57.07 | 53.76 | 43.05 | 51.58 | 50.53 | 50.26 | 44.11 |
| Expenses | 37.16 | 40.03 | 57.22 | 53.24 | 44.51 | 39.57 | 47.73 | 58.50 | 66.56 | 50.75 | 49.91 | 47.21 | 44.15 |
| Operating Profit | 4.33 | 2.45 | 4.41 | -0.49 | -0.99 | 13.32 | 9.34 | -4.74 | -23.51 | 0.83 | 0.62 | 3.05 | -0.04 |
| OPM % | 10.44% | 5.77% | 7.16% | -0.93% | -2.27% | 25.18% | 16.37% | -8.82% | -54.61% | 1.61% | 1.23% | 6.07% | -0.09% |
| Other Income | -0.21 | 0.67 | 0.87 | 0.67 | 0.67 | 0.83 | 3.31 | 2.80 | -0.59 | 1.76 | 1.27 | 2.92 | 1.05 |
| Interest | 0.26 | 0.42 | 1.95 | 1.12 | 1.22 | 2.29 | 4.19 | 4.00 | 1.56 | 3.21 | 0.61 | 1.52 | 2.85 |
| Depreciation | 1.83 | 2.13 | 3.05 | 2.32 | 2.45 | 2.38 | 2.63 | 2.61 | 2.69 | 3.34 | 6.48 | 3.40 | 3.20 |
| Profit before tax | 2.03 | 0.57 | 0.28 | -3.26 | -3.99 | 9.48 | 5.83 | -8.55 | -28.35 | -3.96 | -5.20 | 1.05 | -5.04 |
| Tax % | 25.62% | 91.23% | 235.71% | 9.51% | 6.52% | 6.22% | 22.30% | -1.17% | 2.15% | 12.12% | 19.62% | 43.81% | 3.37% |
| Net Profit | 1.51 | 0.05 | -0.38 | -3.59 | -4.25 | 8.89 | 4.53 | -8.44 | -28.96 | -4.43 | -6.23 | 0.59 | -5.21 |
| EPS in Rs | 0.77 | 0.03 | -0.20 | -1.71 | -1.93 | 4.69 | 2.82 | -4.30 | -14.75 | -2.26 | -3.17 | 0.30 | -2.65 |
Last Updated: January 2, 2026, 4:03 am
Below is a detailed analysis of the quarterly data for Cambridge Technology Enterprises Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 44.11 Cr.. The value appears to be declining and may need further review. It has decreased from 50.26 Cr. (Jun 2025) to 44.11 Cr., marking a decrease of 6.15 Cr..
- For Expenses, as of Sep 2025, the value is 44.15 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 47.21 Cr. (Jun 2025) to 44.15 Cr., marking a decrease of 3.06 Cr..
- For Operating Profit, as of Sep 2025, the value is -0.04 Cr.. The value appears to be declining and may need further review. It has decreased from 3.05 Cr. (Jun 2025) to -0.04 Cr., marking a decrease of 3.09 Cr..
- For OPM %, as of Sep 2025, the value is -0.09%. The value appears to be declining and may need further review. It has decreased from 6.07% (Jun 2025) to -0.09%, marking a decrease of 6.16%.
- For Other Income, as of Sep 2025, the value is 1.05 Cr.. The value appears to be declining and may need further review. It has decreased from 2.92 Cr. (Jun 2025) to 1.05 Cr., marking a decrease of 1.87 Cr..
- For Interest, as of Sep 2025, the value is 2.85 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1.52 Cr. (Jun 2025) to 2.85 Cr., marking an increase of 1.33 Cr..
- For Depreciation, as of Sep 2025, the value is 3.20 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 3.40 Cr. (Jun 2025) to 3.20 Cr., marking a decrease of 0.20 Cr..
- For Profit before tax, as of Sep 2025, the value is -5.04 Cr.. The value appears to be declining and may need further review. It has decreased from 1.05 Cr. (Jun 2025) to -5.04 Cr., marking a decrease of 6.09 Cr..
- For Tax %, as of Sep 2025, the value is 3.37%. The value appears to be improving (decreasing) as expected. It has decreased from 43.81% (Jun 2025) to 3.37%, marking a decrease of 40.44%.
- For Net Profit, as of Sep 2025, the value is -5.21 Cr.. The value appears to be declining and may need further review. It has decreased from 0.59 Cr. (Jun 2025) to -5.21 Cr., marking a decrease of 5.80 Cr..
- For EPS in Rs, as of Sep 2025, the value is -2.65. The value appears to be declining and may need further review. It has decreased from 0.30 (Jun 2025) to -2.65, marking a decrease of 2.95.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:32 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 25 | 32 | 66 | 101 | 99 | 103 | 106 | 109 | 112 | 182 | 206 | 199 | 196 |
| Expenses | 23 | 27 | 54 | 79 | 82 | 80 | 92 | 99 | 95 | 162 | 185 | 225 | 192 |
| Operating Profit | 2 | 6 | 11 | 22 | 17 | 23 | 14 | 11 | 17 | 20 | 21 | -27 | 4 |
| OPM % | 8% | 18% | 17% | 22% | 17% | 22% | 13% | 10% | 15% | 11% | 10% | -13% | 2% |
| Other Income | 1 | 1 | 1 | 4 | 1 | 1 | 2 | 7 | 2 | 3 | 5 | 5 | 7 |
| Interest | 0 | -0 | 0 | 1 | 2 | 1 | 2 | 1 | 1 | 4 | 9 | 9 | 8 |
| Depreciation | 1 | 3 | 6 | 4 | 3 | 3 | 8 | 7 | 7 | 9 | 10 | 15 | 16 |
| Profit before tax | 2 | 4 | 7 | 21 | 12 | 20 | 5 | 9 | 12 | 10 | 8 | -46 | -13 |
| Tax % | 41% | 15% | -38% | 22% | -6% | 5% | 12% | 6% | 17% | 20% | 31% | 4% | |
| Net Profit | 1 | 3 | 9 | 16 | 13 | 19 | 5 | 9 | 10 | 8 | 6 | -48 | -15 |
| EPS in Rs | 0.57 | 1.59 | 4.62 | 8.30 | 5.27 | 9.60 | 2.43 | 4.49 | 4.99 | 4.15 | 2.84 | -24.48 | -7.78 |
| Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 200.00% | 200.00% | 77.78% | -18.75% | 46.15% | -73.68% | 80.00% | 11.11% | -20.00% | -25.00% | -900.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | 0.00% | -122.22% | -96.53% | 64.90% | -119.84% | 153.68% | -68.89% | -31.11% | -5.00% | -875.00% |
Cambridge Technology Enterprises Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 20% |
| 5 Years: | 13% |
| 3 Years: | 21% |
| TTM: | -6% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -1661% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | 10% |
| 3 Years: | -17% |
| 1 Year: | -59% |
| Return on Equity | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | -4% |
| 3 Years: | -12% |
| Last Year: | -53% |
Last Updated: September 5, 2025, 1:30 am
Balance Sheet
Last Updated: December 4, 2025, 1:04 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 |
| Reserves | 6 | 9 | 19 | 26 | 37 | 42 | 54 | 55 | 66 | 79 | 93 | 48 | 48 |
| Borrowings | 0 | 0 | 7 | 12 | 12 | 15 | 18 | 17 | 36 | 57 | 121 | 86 | 80 |
| Other Liabilities | 6 | 5 | 8 | 25 | 20 | 31 | 12 | 23 | 13 | 21 | 39 | 42 | 33 |
| Total Liabilities | 32 | 34 | 54 | 82 | 89 | 107 | 103 | 115 | 134 | 177 | 272 | 196 | 180 |
| Fixed Assets | 13 | 15 | 19 | 9 | 6 | 3 | 21 | 20 | 19 | 37 | 40 | 54 | 52 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 | 22 | 0 | 37 | 2 | 8 |
| Investments | 0 | 0 | 7 | 41 | 36 | 24 | 17 | 11 | 12 | 13 | 18 | 17 | 17 |
| Other Assets | 19 | 19 | 27 | 32 | 47 | 80 | 58 | 83 | 82 | 127 | 178 | 123 | 103 |
| Total Assets | 32 | 34 | 54 | 82 | 89 | 107 | 103 | 115 | 134 | 177 | 272 | 196 | 180 |
Below is a detailed analysis of the balance sheet data for Cambridge Technology Enterprises Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 20.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 20.00 Cr..
- For Reserves, as of Sep 2025, the value is 48.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 48.00 Cr..
- For Borrowings, as of Sep 2025, the value is 80.00 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 86.00 Cr. (Mar 2025) to 80.00 Cr., marking a decrease of 6.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 33.00 Cr.. The value appears to be improving (decreasing). It has decreased from 42.00 Cr. (Mar 2025) to 33.00 Cr., marking a decrease of 9.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 180.00 Cr.. The value appears to be improving (decreasing). It has decreased from 196.00 Cr. (Mar 2025) to 180.00 Cr., marking a decrease of 16.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 52.00 Cr.. The value appears to be declining and may need further review. It has decreased from 54.00 Cr. (Mar 2025) to 52.00 Cr., marking a decrease of 2.00 Cr..
- For CWIP, as of Sep 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 2.00 Cr. (Mar 2025) to 8.00 Cr., marking an increase of 6.00 Cr..
- For Investments, as of Sep 2025, the value is 17.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 17.00 Cr..
- For Other Assets, as of Sep 2025, the value is 103.00 Cr.. The value appears to be declining and may need further review. It has decreased from 123.00 Cr. (Mar 2025) to 103.00 Cr., marking a decrease of 20.00 Cr..
- For Total Assets, as of Sep 2025, the value is 180.00 Cr.. The value appears to be declining and may need further review. It has decreased from 196.00 Cr. (Mar 2025) to 180.00 Cr., marking a decrease of 16.00 Cr..
However, the Borrowings (80.00 Cr.) are higher than the Reserves (48.00 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 2.00 | 6.00 | 4.00 | 10.00 | 5.00 | 8.00 | -4.00 | -6.00 | -19.00 | -37.00 | -100.00 | -113.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 159 | 83 | 49 | 52 | 58 | 226 | 105 | 104 | 92 | 117 | 105 | 91 |
| Inventory Days | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 159 | 83 | 49 | 52 | 58 | 226 | 105 | 104 | 92 | 117 | 105 | 91 |
| Working Capital Days | 127 | 105 | 31 | -34 | 25 | 86 | 62 | 24 | 35 | 70 | 30 | 45 |
| ROCE % | 8% | 13% | 19% | 38% | 22% | 29% | 9% | 10% | 12% | 10% | 9% | -19% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | -24.48 | 2.84 | 4.15 | 4.99 | 4.49 |
| Diluted EPS (Rs.) | -24.48 | 2.84 | 4.15 | 4.99 | 4.49 |
| Cash EPS (Rs.) | -16.78 | 7.83 | 8.61 | 8.33 | 8.21 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 34.61 | 57.29 | 50.54 | 43.49 | 38.08 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 34.61 | 57.29 | 50.54 | 43.49 | 38.08 |
| Revenue From Operations / Share (Rs.) | 101.33 | 105.05 | 92.71 | 57.18 | 55.76 |
| PBDIT / Share (Rs.) | -10.99 | 13.57 | 11.06 | 9.63 | 9.03 |
| PBIT / Share (Rs.) | -18.69 | 8.59 | 6.61 | 6.29 | 5.31 |
| PBT / Share (Rs.) | -23.46 | 4.09 | 5.18 | 5.99 | 4.79 |
| Net Profit / Share (Rs.) | -24.48 | 2.84 | 4.16 | 4.99 | 4.49 |
| NP After MI And SOA / Share (Rs.) | -24.48 | 2.84 | 4.15 | 4.99 | 4.49 |
| PBDIT Margin (%) | -10.84 | 12.92 | 11.93 | 16.84 | 16.19 |
| PBIT Margin (%) | -18.44 | 8.17 | 7.13 | 10.99 | 9.51 |
| PBT Margin (%) | -23.15 | 3.89 | 5.58 | 10.47 | 8.59 |
| Net Profit Margin (%) | -24.16 | 2.70 | 4.48 | 8.72 | 8.04 |
| NP After MI And SOA Margin (%) | -24.16 | 2.70 | 4.47 | 8.72 | 8.04 |
| Return on Networth / Equity (%) | -70.73 | 4.96 | 8.24 | 11.47 | 11.78 |
| Return on Capital Employeed (%) | -29.42 | 9.09 | 9.75 | 11.70 | 12.78 |
| Return On Assets (%) | -24.51 | 2.04 | 4.61 | 7.28 | 7.68 |
| Long Term Debt / Equity (X) | 0.72 | 0.56 | 0.29 | 0.17 | 0.04 |
| Total Debt / Equity (X) | 1.27 | 1.04 | 0.57 | 0.38 | 0.22 |
| Asset Turnover Ratio (%) | 0.84 | 0.91 | 1.17 | 0.47 | 0.43 |
| Current Ratio (X) | 1.63 | 1.83 | 2.44 | 2.62 | 2.27 |
| Quick Ratio (X) | 1.63 | 1.83 | 2.44 | 2.62 | 2.27 |
| Interest Coverage Ratio (X) | -2.30 | 3.02 | 7.72 | 32.01 | 17.64 |
| Interest Coverage Ratio (Post Tax) (X) | -4.13 | 1.63 | 3.90 | 17.58 | 9.77 |
| Enterprise Value (Cr.) | 132.94 | 223.62 | 126.55 | 119.20 | 32.66 |
| EV / Net Operating Revenue (X) | 0.66 | 1.08 | 0.69 | 1.06 | 0.29 |
| EV / EBITDA (X) | -6.16 | 8.39 | 5.83 | 6.30 | 1.84 |
| MarketCap / Net Operating Revenue (X) | 0.33 | 0.78 | 0.53 | 1.09 | 0.45 |
| Price / BV (X) | 0.98 | 1.44 | 0.98 | 1.43 | 0.66 |
| Price / Net Operating Revenue (X) | 0.33 | 0.78 | 0.53 | 1.09 | 0.45 |
| EarningsYield | -0.71 | 0.03 | 0.08 | 0.08 | 0.17 |
After reviewing the key financial ratios for Cambridge Technology Enterprises Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is -24.48. This value is below the healthy minimum of 5. It has decreased from 2.84 (Mar 24) to -24.48, marking a decrease of 27.32.
- For Diluted EPS (Rs.), as of Mar 25, the value is -24.48. This value is below the healthy minimum of 5. It has decreased from 2.84 (Mar 24) to -24.48, marking a decrease of 27.32.
- For Cash EPS (Rs.), as of Mar 25, the value is -16.78. This value is below the healthy minimum of 3. It has decreased from 7.83 (Mar 24) to -16.78, marking a decrease of 24.61.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 34.61. It has decreased from 57.29 (Mar 24) to 34.61, marking a decrease of 22.68.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 34.61. It has decreased from 57.29 (Mar 24) to 34.61, marking a decrease of 22.68.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 101.33. It has decreased from 105.05 (Mar 24) to 101.33, marking a decrease of 3.72.
- For PBDIT / Share (Rs.), as of Mar 25, the value is -10.99. This value is below the healthy minimum of 2. It has decreased from 13.57 (Mar 24) to -10.99, marking a decrease of 24.56.
- For PBIT / Share (Rs.), as of Mar 25, the value is -18.69. This value is below the healthy minimum of 0. It has decreased from 8.59 (Mar 24) to -18.69, marking a decrease of 27.28.
- For PBT / Share (Rs.), as of Mar 25, the value is -23.46. This value is below the healthy minimum of 0. It has decreased from 4.09 (Mar 24) to -23.46, marking a decrease of 27.55.
- For Net Profit / Share (Rs.), as of Mar 25, the value is -24.48. This value is below the healthy minimum of 2. It has decreased from 2.84 (Mar 24) to -24.48, marking a decrease of 27.32.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is -24.48. This value is below the healthy minimum of 2. It has decreased from 2.84 (Mar 24) to -24.48, marking a decrease of 27.32.
- For PBDIT Margin (%), as of Mar 25, the value is -10.84. This value is below the healthy minimum of 10. It has decreased from 12.92 (Mar 24) to -10.84, marking a decrease of 23.76.
- For PBIT Margin (%), as of Mar 25, the value is -18.44. This value is below the healthy minimum of 10. It has decreased from 8.17 (Mar 24) to -18.44, marking a decrease of 26.61.
- For PBT Margin (%), as of Mar 25, the value is -23.15. This value is below the healthy minimum of 10. It has decreased from 3.89 (Mar 24) to -23.15, marking a decrease of 27.04.
- For Net Profit Margin (%), as of Mar 25, the value is -24.16. This value is below the healthy minimum of 5. It has decreased from 2.70 (Mar 24) to -24.16, marking a decrease of 26.86.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is -24.16. This value is below the healthy minimum of 8. It has decreased from 2.70 (Mar 24) to -24.16, marking a decrease of 26.86.
- For Return on Networth / Equity (%), as of Mar 25, the value is -70.73. This value is below the healthy minimum of 15. It has decreased from 4.96 (Mar 24) to -70.73, marking a decrease of 75.69.
- For Return on Capital Employeed (%), as of Mar 25, the value is -29.42. This value is below the healthy minimum of 10. It has decreased from 9.09 (Mar 24) to -29.42, marking a decrease of 38.51.
- For Return On Assets (%), as of Mar 25, the value is -24.51. This value is below the healthy minimum of 5. It has decreased from 2.04 (Mar 24) to -24.51, marking a decrease of 26.55.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.72. This value is within the healthy range. It has increased from 0.56 (Mar 24) to 0.72, marking an increase of 0.16.
- For Total Debt / Equity (X), as of Mar 25, the value is 1.27. This value exceeds the healthy maximum of 1. It has increased from 1.04 (Mar 24) to 1.27, marking an increase of 0.23.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.84. It has decreased from 0.91 (Mar 24) to 0.84, marking a decrease of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 1.63. This value is within the healthy range. It has decreased from 1.83 (Mar 24) to 1.63, marking a decrease of 0.20.
- For Quick Ratio (X), as of Mar 25, the value is 1.63. This value is within the healthy range. It has decreased from 1.83 (Mar 24) to 1.63, marking a decrease of 0.20.
- For Interest Coverage Ratio (X), as of Mar 25, the value is -2.30. This value is below the healthy minimum of 3. It has decreased from 3.02 (Mar 24) to -2.30, marking a decrease of 5.32.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -4.13. This value is below the healthy minimum of 3. It has decreased from 1.63 (Mar 24) to -4.13, marking a decrease of 5.76.
- For Enterprise Value (Cr.), as of Mar 25, the value is 132.94. It has decreased from 223.62 (Mar 24) to 132.94, marking a decrease of 90.68.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.66. This value is below the healthy minimum of 1. It has decreased from 1.08 (Mar 24) to 0.66, marking a decrease of 0.42.
- For EV / EBITDA (X), as of Mar 25, the value is -6.16. This value is below the healthy minimum of 5. It has decreased from 8.39 (Mar 24) to -6.16, marking a decrease of 14.55.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.33. This value is below the healthy minimum of 1. It has decreased from 0.78 (Mar 24) to 0.33, marking a decrease of 0.45.
- For Price / BV (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 1.44 (Mar 24) to 0.98, marking a decrease of 0.46.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.33. This value is below the healthy minimum of 1. It has decreased from 0.78 (Mar 24) to 0.33, marking a decrease of 0.45.
- For EarningsYield, as of Mar 25, the value is -0.71. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to -0.71, marking a decrease of 0.74.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Cambridge Technology Enterprises Ltd:
- Net Profit Margin: -24.16%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: -29.42% (Industry Average ROCE: 20.61%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: -70.73% (Industry Average ROE: 18.63%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): -4.13
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.63
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 43.58)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.27
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: -24.16%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | Capital Park, 4th Floor, Unit No. 403B & 404, Plot No. 1-98/4/1-13, 28 & 29, Survey No.72, Hyderabad Telangana 500081 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Dharani Raghurama Swaroop | Whole Time Director |
| Mr. Stefan Hetges | Non Executive Director |
| Mrs. Jayalakshmi Kumari Kanukollu | Non Executive Director |
| Mr. Raj Kumar Sehgal | Non Executive Director |
| Ms. Manjula Aleti | Independent Director |
| Mr. Srinivas Medepalli | Independent Director |
| Mr. Sridhar Lalpet | Independent Director |
| Mr. Tarakad Narayanan Kannan | Independent Director |
FAQ
What is the intrinsic value of Cambridge Technology Enterprises Ltd?
Cambridge Technology Enterprises Ltd's intrinsic value (as of 29 January 2026) is ₹132.46 which is 307.57% higher the current market price of ₹32.50, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹63.8 Cr. market cap, FY2025-2026 high/low of ₹89.3/32.2, reserves of ₹48 Cr, and liabilities of ₹180 Cr.
What is the Market Cap of Cambridge Technology Enterprises Ltd?
The Market Cap of Cambridge Technology Enterprises Ltd is 63.8 Cr..
What is the current Stock Price of Cambridge Technology Enterprises Ltd as on 29 January 2026?
The current stock price of Cambridge Technology Enterprises Ltd as on 29 January 2026 is ₹32.5.
What is the High / Low of Cambridge Technology Enterprises Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Cambridge Technology Enterprises Ltd stocks is ₹89.3/32.2.
What is the Stock P/E of Cambridge Technology Enterprises Ltd?
The Stock P/E of Cambridge Technology Enterprises Ltd is .
What is the Book Value of Cambridge Technology Enterprises Ltd?
The Book Value of Cambridge Technology Enterprises Ltd is 34.5.
What is the Dividend Yield of Cambridge Technology Enterprises Ltd?
The Dividend Yield of Cambridge Technology Enterprises Ltd is 0.00 %.
What is the ROCE of Cambridge Technology Enterprises Ltd?
The ROCE of Cambridge Technology Enterprises Ltd is 18.8 %.
What is the ROE of Cambridge Technology Enterprises Ltd?
The ROE of Cambridge Technology Enterprises Ltd is 53.0 %.
What is the Face Value of Cambridge Technology Enterprises Ltd?
The Face Value of Cambridge Technology Enterprises Ltd is 10.0.